ECSP034898A - 2,5-DIARILPIRAZINAS, 2,5-DIARILPIRIDINAS and 2,5- DIARILPIRIMIDINAS - Google Patents
2,5-DIARILPIRAZINAS, 2,5-DIARILPIRIDINAS and 2,5- DIARILPIRIMIDINASInfo
- Publication number
- ECSP034898A ECSP034898A EC2003004898A ECSP034898A ECSP034898A EC SP034898 A ECSP034898 A EC SP034898A EC 2003004898 A EC2003004898 A EC 2003004898A EC SP034898 A ECSP034898 A EC SP034898A EC SP034898 A ECSP034898 A EC SP034898A
- Authority
- EC
- Ecuador
- Prior art keywords
- compounds
- disorders
- crf
- useful
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0463—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Se suministran compuestos de diarilpirazina, diarilpiridina y diarilpirimidina que actúan como moduladores selectivos de los receptores CRF 1. Estos compuestos son útiles en el tratamiento de un número de trastornos periféricos y del sistema nervioso central, particularmente estrés, ansiedad, depresión, trastornos cardiovasculares y trastornos de alimentación. Se suministran también métodos para tratar tales trastornos así como composiciones farmacéuticas empacadas. Los compuestos de fórmula I son también útiles para tratar de encontrar la localización de los receptores CRF y como patrones en los ensayos para unión del receptor CRF. Se suministran también métodos de uso de los compuestos en los estudios de localización del receptor.Compounds of diarylpyrazine, diarylpyridine and diarylpyrimidine are provided which act as selective modulators of the CRF 1 receptors. These compounds are useful in the treatment of a number of peripheral disorders and the central nervous system, particularly stress, anxiety, depression, cardiovascular disorders and disorders. of feeding. Methods for treating such disorders as well as packaged pharmaceutical compositions are also provided. The compounds of formula I are also useful in trying to find the location of CRF receptors and as standards in assays for CRF receptor binding. Methods of using the compounds in receptor location studies are also provided.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29748301P | 2001-06-12 | 2001-06-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP034898A true ECSP034898A (en) | 2004-01-28 |
Family
ID=23146501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2003004898A ECSP034898A (en) | 2001-06-12 | 2003-12-12 | 2,5-DIARILPIRAZINAS, 2,5-DIARILPIRIDINAS and 2,5- DIARILPIRIMIDINAS |
Country Status (16)
Country | Link |
---|---|
US (2) | US6887875B2 (en) |
EP (1) | EP1399428A1 (en) |
JP (1) | JP2005500286A (en) |
AP (1) | AP2003002924A0 (en) |
BG (1) | BG108427A (en) |
CA (1) | CA2450262A1 (en) |
EC (1) | ECSP034898A (en) |
HR (1) | HRP20031096A2 (en) |
HU (1) | HUP0400179A3 (en) |
IL (1) | IL159058A0 (en) |
IS (1) | IS7060A (en) |
MX (1) | MXPA03011391A (en) |
PL (1) | PL367476A1 (en) |
RU (1) | RU2003136151A (en) |
TN (1) | TNSN03133A1 (en) |
WO (1) | WO2002100838A1 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020072521A1 (en) * | 2000-03-16 | 2002-06-13 | Taeyoung Yoon | 5-substituted arylpyrimidines |
EP1499599A1 (en) * | 2002-04-26 | 2005-01-26 | Pharmacia & Upjohn Company LLC | Substituted pyrazine derivatives |
ATE325115T1 (en) | 2002-08-19 | 2006-06-15 | Glaxo Group Ltd | PYRIMIDINE DERIVATIVES AS SELECTIVE COX-2 INHIBITORS |
GB0221443D0 (en) | 2002-09-16 | 2002-10-23 | Glaxo Group Ltd | Pyridine derivates |
BR0315845A (en) * | 2002-11-21 | 2005-09-27 | Pharmacia & Upjohn Co Llc | Pyrazine Compounds as Crf Modulators |
CN100554264C (en) * | 2003-11-24 | 2009-10-28 | 弗·哈夫曼-拉罗切有限公司 | Pyrazolyl and imidazolyl pyrimidines |
JP2008505957A (en) * | 2004-07-14 | 2008-02-28 | ビーエーエスエフ アクチェンゲゼルシャフト | 2-substituted pyrimidines, their preparation and their use for controlling harmful fungi |
TW200637556A (en) * | 2005-01-31 | 2006-11-01 | Basf Ag | Substituted 5-phenyl pyrimidines I in therapy |
CN101258142A (en) | 2005-08-02 | 2008-09-03 | 莱西肯医药有限公司 | 2-aminoaryl pyridines as protein kinases inhibitors |
TW200908984A (en) * | 2007-08-07 | 2009-03-01 | Piramal Life Sciences Ltd | Pyridyl derivatives, their preparation and use |
US7932256B2 (en) * | 2008-07-31 | 2011-04-26 | Bristol-Myers Squibb Company | (S)-4-(1-cyclopropyl-2-methoxyethyl)-6-(6-(difluoromethoxy)-2,5-dimethylpyridin-3-ylamino)-5-oxo-4,5-dihydropyrazine-2-carbonitrile: a pyrazinone modulator of corticotropin-releasing factor receptor activity |
WO2011051478A1 (en) * | 2009-10-30 | 2011-05-05 | Domain Therapeutics | Novel oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors |
WO2014179785A1 (en) | 2013-05-03 | 2014-11-06 | Inscent, Inc. | Improved honeybee repellents and uses thereof |
WO2014179786A1 (en) * | 2013-05-03 | 2014-11-06 | Inscent, Inc. | Improved honeybee repellents and uses thereof |
CN103788367B (en) * | 2014-02-26 | 2017-01-11 | 中国科学院长春应用化学研究所 | Polyesteramide and preparation method thereof |
JP2022074173A (en) * | 2019-03-18 | 2022-05-18 | 住友化学株式会社 | Method for producing 2,5-dichloropyrazine |
CN112142716B (en) * | 2020-10-29 | 2021-08-31 | 山东新时代药业有限公司 | 5-membered heteroaryl substituted pyrazine derivative and application thereof |
CN113429354A (en) * | 2021-07-22 | 2021-09-24 | 广东嘉博制药有限公司 | Methoxamine hydrochloride polymer impurity and preparation method thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1463813A (en) * | 1964-02-26 | 1966-07-22 | Ciba Geigy | New amino-phenylketones and process for their preparation |
US3660404A (en) * | 1969-02-24 | 1972-05-02 | Du Pont | U.v.-absorbing ortho-hydroxyphenyl substituted bipyrimidyls |
DE2064380C3 (en) * | 1970-12-30 | 1981-01-22 | Hoechst Ag, 6000 Frankfurt | Photosensitive mixture |
JPS625970A (en) | 1985-03-15 | 1987-01-12 | Terumo Corp | Pyrazine derivative and platelet coagulation inhibitor containing same |
EP0339252B1 (en) * | 1988-04-25 | 1996-06-12 | Dainippon Ink And Chemicals, Inc. | 2,5-disubstituted pyrazine derivatives, pyrimidine derivatives, and liquid crystal containing the same |
JPH02209873A (en) * | 1989-02-08 | 1990-08-21 | Dainippon Ink & Chem Inc | Optically active 2,5-disubstituted pyrimidine derivative |
JP2770385B2 (en) * | 1989-03-16 | 1998-07-02 | セイコーエプソン株式会社 | Pyrimidine derivatives |
WO1995010506A1 (en) * | 1993-10-12 | 1995-04-20 | The Du Pont Merck Pharmaceutical Company | 1n-alkyl-n-arylpyrimidinamines and derivatives thereof |
JPH0948760A (en) * | 1995-08-03 | 1997-02-18 | Dainippon Ink & Chem Inc | Pyrimidine compound |
JP4044175B2 (en) * | 1996-07-26 | 2008-02-06 | 株式会社半導体エネルギー研究所 | Optically active compound and antiferroelectric liquid crystal composition containing the compound |
US6686486B1 (en) * | 1997-05-07 | 2004-02-03 | Padma Marwah | Process for effecting allylic oxidation |
SE9702651D0 (en) * | 1997-07-09 | 1997-07-09 | Astra Pharma Prod | Novel compounds |
PL341984A1 (en) * | 1998-01-28 | 2001-05-07 | Shionogi & Co | Novel tricycle compounds |
CO5210940A1 (en) * | 1999-05-04 | 2002-10-30 | Novartis Ag | PESTICIDES PESTICIDES DERIVED FROM PIRIMIDINE AND COMPOSITIONS CONTAINING THEM |
AU783915B2 (en) * | 2000-02-16 | 2005-12-22 | Neurogen Corporation | Substituted arylpyrazines |
-
2002
- 2002-05-22 EP EP02737167A patent/EP1399428A1/en not_active Withdrawn
- 2002-05-22 PL PL02367476A patent/PL367476A1/en not_active Application Discontinuation
- 2002-05-22 HU HU0400179A patent/HUP0400179A3/en unknown
- 2002-05-22 IL IL15905802A patent/IL159058A0/en unknown
- 2002-05-22 WO PCT/US2002/016518 patent/WO2002100838A1/en not_active Application Discontinuation
- 2002-05-22 US US10/154,482 patent/US6887875B2/en not_active Expired - Fee Related
- 2002-05-22 MX MXPA03011391A patent/MXPA03011391A/en unknown
- 2002-05-22 CA CA002450262A patent/CA2450262A1/en not_active Abandoned
- 2002-05-22 RU RU2003136151/04A patent/RU2003136151A/en not_active Application Discontinuation
- 2002-05-22 JP JP2003503606A patent/JP2005500286A/en active Pending
- 2002-05-22 AP APAP/P/2003/002924A patent/AP2003002924A0/en unknown
-
2003
- 2003-07-08 TN TNPCT/US2002/016518A patent/TNSN03133A1/en unknown
- 2003-11-28 IS IS7060A patent/IS7060A/en unknown
- 2003-12-08 BG BG108427A patent/BG108427A/en unknown
- 2003-12-12 EC EC2003004898A patent/ECSP034898A/en unknown
- 2003-12-30 HR HR20031096A patent/HRP20031096A2/en not_active Application Discontinuation
-
2005
- 2005-04-04 US US11/098,885 patent/US20050176721A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AP2003002924A0 (en) | 2003-12-31 |
TNSN03133A1 (en) | 2005-12-23 |
HUP0400179A3 (en) | 2004-10-28 |
HUP0400179A2 (en) | 2004-08-30 |
IL159058A0 (en) | 2004-05-12 |
PL367476A1 (en) | 2005-02-21 |
RU2003136151A (en) | 2005-05-20 |
JP2005500286A (en) | 2005-01-06 |
WO2002100838A1 (en) | 2002-12-19 |
HRP20031096A2 (en) | 2005-08-31 |
IS7060A (en) | 2003-11-28 |
EP1399428A1 (en) | 2004-03-24 |
US20050176721A1 (en) | 2005-08-11 |
MXPA03011391A (en) | 2004-07-01 |
US20030119844A1 (en) | 2003-06-26 |
US6887875B2 (en) | 2005-05-03 |
CA2450262A1 (en) | 2002-12-19 |
BG108427A (en) | 2005-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP034898A (en) | 2,5-DIARILPIRAZINAS, 2,5-DIARILPIRIDINAS and 2,5- DIARILPIRIMIDINAS | |
UY28150A1 (en) | THERAPEUTIC AGENTS | |
ECSP034428A (en) | CYCLOPENTHANOLS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND THEIR USE | |
CR8254A (en) | [1,8] NAFTIDRIN-2-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA | |
PA8615701A1 (en) | DERIVATIVES OF DIHYDROBENZOFURANYL ALCANAMINE AND METHODS FOR USE. | |
AR028824A1 (en) | NPY-5 ANTAGONIST COMPOUNDS AND ITS USE IN THE MANUFACTURE OF MEDICINES. | |
SV2006002098A (en) | MORFOLINE COMPOUNDS REPLACED FOR THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM REF. PC32250A | |
CR9135A (en) | NOVEDOUS PIRROLIDILE DERIVATIVES OF HETEROAROMATIC COMPOUNDS | |
CY1109015T1 (en) | DIFFINYL UNIONS USEFUL AS MUSCARIAN RECEPTOR COMPONENTS | |
UY28374A1 (en) | THERAPEUTIC AGENTS | |
DE60025604D1 (en) | Benzimidazole derivatives and pharmaceutical compositions containing them | |
GT199900146A (en) | DERIVATIVES OF 4,4-BIARYLIPIPERIDINE. | |
UY28752A1 (en) | THERAPEUTIC AGENTS | |
IS8377A (en) | Arylindenopyridine and arylindenopyrimidine and their use as antagonists of the A2A adenosine receptor | |
UY28538A1 (en) | PHENYL-PIPERAZINE DERIVATIVES AS MUSCARINIC RECEPTORS MODULATORS | |
UY28839A1 (en) | THERAPEUTIC AGENTS | |
ECSP034860A (en) | 5-SUBSTITUTES-2-ARILPIRIDINAS AS MODULATORS OF CORTICOTROPINE RELEASE FACTOR 1 | |
CR9407A (en) | TETRAHYDROPIRIDOAZEPIN-8-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA | |
UY27232A1 (en) | NEW SUBSTITUTED CYAN DIHYDROPIRIMIDINE COMPOUNDS AND THEIR USE FOR TREATMENT OF MATTERS | |
CR7735A (en) | HETEROCICLIC PIPERIZINES REPLACED FOR THE TREATMENT OF CHICHOPHRENIA | |
ATE384066T1 (en) | THIENO-PYRROLE COMPOUNDS AS ANTAGONISTS OF GONADOTROPIN-REleasing HORMONE RECEPTORS | |
MXPA05012572A (en) | 5-h -benzo [d] naphth [2, 1-b] azepine derivative as selective d1. | |
CR7201A (en) | 2,5- DIARILPIRAZINAS, 2,5- DIARILPIRIDINAS AND 2,5- DIARILPIRIMIDINAS AS MODULATORS OF THE CRF1 RECEPTOR | |
UY28476A1 (en) | (1,8) NAFTIRIN-2-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA | |
ECSP992990A (en) | RECEPTOR AGONISTS ß2- ADRENERGICOS |